Furthermore, suppression of SCL38A2 also induced apoptosis (Supplementary Fig. 7f) and suppressed OXPHOS (Supplementary Fig. 7g–k) in SMARCA4/2-deficient cancer cells but not in controls, phenocopying glutamine deprivation. Here, SMARCA4 is linked to cancer.